$5.83
0.30[5.42%]
Last update: 8:40AM Get Real Time Here
Mesoblast
(NASDAQ:MESO)Mesoblast Stock (NASDAQ:MESO), Analyst Ratings, Price Targets, Predictions
Mesoblast Ltd has a consensus price target of $3.42, established from looking at the 14 latest analyst ratings. The last 3 analyst ratings were released from Cantor Fitzgerald, Jefferies, and Cantor Fitzgerald on September 21, 2023, August 31, 2023, and August 31, 2023. With an average price target of $11.33 between Cantor Fitzgerald, Jefferies, and Cantor Fitzgerald, there's an implied 84.28% upside for Mesoblast Ltd from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
Jefferies
Maxim Group
William Blair
Piper Sandler
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Mesoblast
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 09/21/2023 | MESO | Buy Now | Mesoblast | $6.15 | 176.42% | Cantor Fitzgerald | Louise Chen | → $68 | Reiterates | Overweight → Overweight | Get Alert |
| 08/31/2023 | MESO | Buy Now | Mesoblast | $6.15 | — | Jefferies | David Stanton | — | Upgrade | Hold → Buy | Get Alert |
| 08/31/2023 | MESO | Buy Now | Mesoblast | $6.15 | 176.42% | Cantor Fitzgerald | Louise Chen | $92 → $68 | Maintains | Overweight | Get Alert |
| 08/07/2023 | MESO | Buy Now | Mesoblast | $6.15 | — | Maxim Group | Jason McCarthy | — | Downgrade | Buy → Hold | Get Alert |
| 08/04/2023 | MESO | Buy Now | Mesoblast | $6.15 | — | William Blair | Sami Corwin | — | Downgrade | Outperform → Market Perform | Get Alert |
| 08/04/2023 | MESO | Buy Now | Mesoblast | $6.15 | -67.48% | Piper Sandler | Edward Tenthoff | $28 → $8 | Downgrade | Overweight → Neutral | Get Alert |
| 08/04/2023 | MESO | Buy Now | Mesoblast | $6.15 | -75.61% | Chardan Capital | Keay Nakae | $8 → $6 | Maintains | Sell | Get Alert |
| 05/30/2023 | MESO | Buy Now | Mesoblast | $6.15 | -67.48% | Chardan Capital | Keay Nakae | $10 → $8 | Maintains | Sell | Get Alert |
| 03/01/2023 | MESO | Buy Now | Mesoblast | $6.15 | -59.35% | Chardan Capital | Keay Nakae | → $10 | Reiterates | → Sell | Get Alert |
| 02/01/2023 | MESO | Buy Now | Mesoblast | $6.15 | 273.98% | Cantor Fitzgerald | Louise Chen | → $92 | Reiterates | → Overweight | Get Alert |
| 12/06/2022 | MESO | Buy Now | Mesoblast | $6.15 | — | Jefferies | David Stanton | — | Downgrade | Buy → Hold | Get Alert |
| 09/06/2022 | MESO | Buy Now | Mesoblast | $6.15 | 13.82% | Piper Sandler | Edward Tenthoff | → $28 | Initiates | → Overweight | Get Alert |
| 06/03/2022 | MESO | Buy Now | Mesoblast | $6.15 | -59.35% | Chardan Capital | Keay Nakae | $26 → $10 | Maintains | Sell | Get Alert |
| 08/31/2021 | MESO | Buy Now | Mesoblast | $6.15 | 5.69% | Chardan Capital | Keay Nakae | $30 → $26 | Maintains | Sell | Get Alert |
FAQ
What is the target price for Mesoblast (MESO)?
The latest price target for Mesoblast (NASDAQ: MESO) was reported by Cantor Fitzgerald on September 21, 2023. The analyst firm set a price target for $17.00 expecting MESO to rise to within 12 months (a possible 191.60% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Mesoblast (MESO)?
The latest analyst rating for Mesoblast (NASDAQ: MESO) was provided by Cantor Fitzgerald, and Mesoblast reiterated their overweight rating.
When was the last upgrade for Mesoblast (MESO)?
The last upgrade for Mesoblast Ltd happened on August 31, 2023 when Jefferies raised their price target to N/A. Jefferies previously had a hold for Mesoblast Ltd.
When was the last downgrade for Mesoblast (MESO)?
The last downgrade for Mesoblast Ltd happened on August 7, 2023 when Maxim Group changed their price target from N/A to N/A for Mesoblast Ltd.
When is the next analyst rating going to be posted or updated for Mesoblast (MESO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mesoblast, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mesoblast was filed on September 21, 2023 so you should expect the next rating to be made available sometime around September 21, 2024.
Is the Analyst Rating Mesoblast (MESO) correct?
While ratings are subjective and will change, the latest Mesoblast (MESO) rating was a reiterated with a price target of $0.00 to $17.00. The current price Mesoblast (MESO) is trading at is $5.83, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.